AzTrials
AzTrials

Neck PainNCT03136250

Effects of Autogenic and Reciprocal Inhibition, Muscle Energy Techniques in the Management of Mechanical Neck Pain

A study testing Group B (Autogenic Inhibition - PIR + Standard treatment) and Group C (Reciprocal Inhibition - RI + Standard treatment) in people with Neck Pain, run by Foundation University Islamabad at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Neck pain is among the most common musculoskeletal disorders worldwide and is an important public health issue in terms of personal wellbeing. Prevalence of neck pain show excessive variations, with a point prevalence varying between 6% and 22%, and one year prevalence ranging between 1.5-75%. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Neck Pain
What is being tested?
Group B (Autogenic Inhibition - PIR + Standard treatment) and Group C (Reciprocal Inhibition - RI + Standard treatment)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
78 participants
Where
1 sitePakistan
Study dates
11 Apr 2017to 30 Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age 18 to 70 years;
  • Neck pain on NPRS 4 to 8 (moderate cases);
  • Subacute or chronic cases (4 to 12 weeks).
  • Decreased or painful Cervical range of motion (CROM)

Who cannot join

  • Signs of serious pathology (e.g., malignancy, inflammatory disorder, infection);
  • History of cervical spine surgery in previous 12 months;
  • History of trauma or fractures in cervical spine;
  • Signs of cervical radiculopathy or myelopathy; and
  • Vascular syndromes such as VBI

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Foundation University Institute of Rehabilitation Sciences

    Islamabad

Other trials in Pakistan

About this study

Neck pain is among the most common musculoskeletal disorders worldwide and is an important public health issue in terms of personal wellbeing. Prevalence of neck pain show excessive variations, with a point prevalence varying between 6% and 22%, and one year prevalence ranging between 1.5-75%. Neck pain like all other mechanical disorders leads to pain, disability and decreased range of motion (ROM). Stretching is a very common exercise performed by sportsmen, elderly, in physical therapy and rehabilitation patients, thus practiced in all sorts of fitness programs. The major types of stretching included in the literature are static, dynamic and pre-contraction stretching; of which static stretching is the conventional type of stretching. The different types of pre-contraction stretching include Proprioceptive Neuromuscular Facilitation (PNF) stretching, Post Isometric Relaxation (PIR), Post Facilitation stretch (PFS) and Active Isolated Stretch (AIS). Pre-contraction stretching is also considered a part of Muscle Energy Technique (MET). Recently MET and pre-contraction stretching have been shown to have significant superiority over conventional stretching in management of mechanical neck pain, but the evidence is currently lacking regarding which of the two pre-contraction stretching protocols, namely autogenic and reciprocal inhibition is more effective than the other. A RCT will be conducted in order to find and compare the effectiveness of conventional stretching and pre-contraction stretching (autogenic inhibition and reciprocal inhibition). One Control group (conventional group) and two Experimental groups (Experimental Group A - Autogenic Inhibition \& Experimental Group B - Reciprocal Inhibition) will be formed. The participants will be recruited in the study if they meet the inclusion criteria using consecutive sampling from Fauji Foundation Hospital and randomized into the three respective groups. All the groups will receive the gold standard treatment for chronic neck pain including mobilization and modalities. In addition to the gold standard treatment the participants will receive specific stretching protocol based on their interventional group

Conditions
Neck Pain
Being tested
Group A (Control Group - Static Stretching + Standard Treatment), Group B (Autogenic Inhibition - PIR + Standard treatment), Group C (Reciprocal Inhibition - RI + Standard treatment)
Keywords
Muscle Energy Techniques, Autogenic Inhibition, Reciprocal Inhibition, Stretching, Range of Motion, Muscle Strength, VAS, Neck Disability Index, NDI
Medical subject headings
Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group A (Control Group - Static Stretching + Standard Treatment)Other

    • Conventional Gold Standard treatment (Manual Therapy + Modalities) Conventional Static Stretching 15-30 seconds hold 3-5 repetitions (Page P, 2012) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid, Levator Scapulae and Upper Trapezius Muscles.
  • Group B (Autogenic Inhibition - PIR + Standard treatment)Other

    • Conventional Gold Standard treatment (Manual Therapy + Modalities) Post Isometric Relaxation MET (3-5 reps) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid, Levator Scapulae and Upper Trapezius Muscles. (Chaitow L, 2006)
  • Group C (Reciprocal Inhibition - RI + Standard treatment)Other

    • Conventional Gold Standard treatment (Manual Therapy + Modalities) Reciprocal Inhibition MET (3-5 reps) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid,Levator Scapulae and Upper Trapezius Muscles (Chaitow L, 2006)
Study groups in NCT03136250
Study groupRoleWhat they receive
Group A (Control Group - Static Stretching)Active comparator(Control Group - Static Stretching + Standard Treatment)
Receives: Other: Group A (Control Group - Static Stretching + Standard Treatment)
Group B (Autogenic Inhibition MET)Experimental(Autogenic Inhibition - PIR + Standard treatment)
Receives: Other: Group B (Autogenic Inhibition - PIR + Standard treatment)
Group C (Reciprocal Inhibition MET)Experimental(Reciprocal Inhibition - RI + Standard treatment)
Receives: Other: Group C (Reciprocal Inhibition - RI + Standard treatment)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain (Numeric Pain Rating Scale) - Change is being assessed

    To measure the pre and post patient's perception of pain

    Measured: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

  2. Cervical Range of Motion (CROM) - Change is being assessed

    To measure patient's improvement in cervical range of motion

    Measured: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

  3. Neck Disability Index (NDI) - Change is being assessed

    to measure patient's pre and post functional disability

    Measured: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

  4. Cervical Isometric Muscle Strength (Modified Sphygmomanometer dynamometry) - Change is being assessed

    To measure patient's improvement in Isometric Muscle Strength

    Measured: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2017
  2. Study start11 Apr 2017
  3. Primary completion30 Nov 2017
  4. Study completion30 Dec 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
A randomized Controlled trial will be conducted in order to find and compare the effectiveness of conventional stretching and MET stretching (autogenic inhibition and reciprocal inhibition). One Control group (conventional group) and two Experimental groups (Experimental Group A - Autogenic Inhibition \& Experimental Group B - Reciprocal Inhibition) will be formed. The participants will be recruited in the study if they meet the inclusion criteria using consecutive sampling from Fauji Foundation Hospital and randomized into the three respective groups. All the groups will receive the gold standard treatment for chronic neck pain including mobilization and modalities. In addition to the gold standard treatment the participants will receive specific stretching protocol based on their interventional group.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
78 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03136250
Sponsor's protocol ID
FUI/CTR/2017/1
Status last verified
Dec 2017
First submitted
10 Apr 2017
Last updated
8 Feb 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Group B (Autogenic Inhibition - PIR + Standard treatment) and Group C (Reciprocal Inhibition - RI + Standard treatment) in people with Neck Pain, run by Foundation University Islamabad at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain (Numeric Pain Rating Scale) - Change is being assessed (time frame: Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Feb 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in